資訊|論壇|病例

搜索

首頁 醫(yī)學(xué)論壇 專業(yè)文章 醫(yī)學(xué)進展 簽約作者 病例中心 快問診所 愛醫(yī)培訓(xùn) 醫(yī)學(xué)考試 在線題庫 醫(yī)學(xué)會議

您所在的位置:首頁 > 腫瘤科診療指南 > 2009CCO/PET成像用于胰腺癌診斷

2009CCO/PET成像用于胰腺癌診斷

2014-05-23 15:57 閱讀:2336 來源:愛愛醫(yī) 責(zé)任編輯:張子玲
[導(dǎo)讀] In some cases where sufficient evidence existed, meta-**yses were included withpooled likelihood ratios.

    《2009CCO/PET成像用于胰腺癌診斷》內(nèi)容簡介:

    In some cases where sufficient evidence existed, meta-**yses were included withpooled likelihood ratios. The AHRQ review included evidence tables that summarized thecharacteristics and results of each study according to the outcomes the study addressed. Fordiagnostic performance, the evidence tables recorded details on the source of the publicationand the evidence grade, study design, patient characteristics, PET technical characteristics,criteria for interpretation, and results.

    《2009CCO/PET成像用于胰腺癌診斷》內(nèi)容預(yù)覽:

   
Provincial Consensus Process

    The consensus meeting on 25 November 2008 was conducted as follows:

    Presentations by each of the clinical lead authors on the DRAFT DSG recommendations

    and supporting evidence were made to the meeting participants.

    The recommendations were refined by the large group, and in some cases a revised

    recommendation was proposed, resulting in a FINAL recommendation.

    The participants voted on the FINAL recommendations to indicate their extent of

    agreement on a scale from 1 to 7 (1 indicating strong agreement, 5 indicating no

    agreement or disagreement, and 7 indicating strong disagreement)。

    RESULTS

    Literature Search Results

    The AHRQ review results for pancreatic cancer included 17 primary studies. Data from

    the evidence tables are summarized in Appendix 1. In addition to data for diagnostic

    performance, summaries of results for diagnostic thinking and management strategy are also

    presented where they apply. The key evidence is described below in an abbreviated fashion.

    Key Evidence

    Diagnosis/Staging

    Eleven prospective studies were identified that evaluated the role of PET or PET/CT in the

    diagnosis of a suspicious pancreatic mass. Sensitivity ranged from 69% to 97%, and

    specificity ranged from 61% to 97% (Giorgi2004 [3], Nishiyama2005-100 [4], Rasmussen2004

    [5], van Kouwen2005 [6], Bang2006 [7], Heinrich2005 [8], Lemke2004 [9], Lytras2005 [10],

    Maemura2006 [11], Sperti2007 [12], Casneuf2007 [13])。


    點擊下載***:《2009CCO/PET成像用于胰腺癌診斷》


分享到:
  版權(quán)聲明:

  本站所注明來源為"愛愛醫(yī)"的文章,版權(quán)歸作者與本站共同所有,非經(jīng)授權(quán)不得轉(zhuǎn)載。

  本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉(zhuǎn)載的媒體或個人可與我們

  聯(lián)系zlzs@120.net,我們將立即進行刪除處理

意見反饋 關(guān)于我們 隱私保護 版權(quán)聲明 友情鏈接 聯(lián)系我們

Copyright 2002-2024 Iiyi.Com All Rights Reserved